The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery
Primary Purpose
Coagulation; Intravascular, Rotational Thromboelastometry, Fibrinolysis; Hemorrhage
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Tranexamic Acid
Placebo
Sponsored by

About this trial
This is an interventional treatment trial for Coagulation; Intravascular focused on measuring tranexamic acid, Rotational thromboelastometry, Fibrinolysis, viscoelastic essay
Eligibility Criteria
Inclusion Criteria:
- The study population will include total of 200 adults (age range of 18 - 85 years) who are in the American Society of Anesthesiologists (ASA) Physical Status (PS) 1-3. Inclusion criteria are patients undergoing unilateral, primary, total hip arthroplasty.
Exclusion Criteria:
- Exclusion criteria include patient's refusal, patients with history of significant coagulopathy or on anticoagulation therapy. Female patients who are pregnant or nursing will be excluded. In addition, patients with anemia (Hb < 8 g/dL) or who received blood transfusion within one week before surgery will be excluded. Patient receiving subcutaneous heparin on the same day prior to surgery will be also excluded.
Sites / Locations
- Thomas Jefferson University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
tranexamic acid
Normal saline
Arm Description
Patients undergoing unilateral, primary, total hip arthroplasty with English as their native language
Patients undergoing unilateral, primary, total hip arthroplasty with English as their native language
Outcomes
Primary Outcome Measures
Fibrinolysis
Fibrinolysis based on ROTEM parameter, defined as ML (maxium lysis) >15%
Fibrinolysis
Fibrinolysis based on ROTEM parameter, defined as ML (maxium lysis) >15%
Fibrinolysis
Fibrinolysis based on ROTEM parameter, defined as ML (maxium lysis) >15%
Secondary Outcome Measures
Blood loss
amount of blood loss in milliliter during surgery
blood transfusion
Amount of Packed Red Blood Cells (PRBC) transfused
pre- and postoperative hemoglobin level
Pre and postoperative hemoglobin level in grams per deciliter
Wound infection
Incidence of wound infection
Hematoma
Incidence of hematoma
Thrombotic events (PE, DVT).
Incidence of thrombotic events (pulmonary embolism, deep vein thrombosis)
Full Information
NCT ID
NCT03897621
First Posted
March 26, 2019
Last Updated
April 12, 2023
Sponsor
Thomas Jefferson University
1. Study Identification
Unique Protocol Identification Number
NCT03897621
Brief Title
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery
Official Title
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery Based on Rotational Thromboelastometry (ROTEM®).
Study Type
Interventional
2. Study Status
Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
May 20, 2019 (Actual)
Primary Completion Date
December 20, 2022 (Actual)
Study Completion Date
December 20, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Thomas Jefferson University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Total hip arthroplasty (THA) is associated with blood loss ranging from 300 to 2000 mL. Tranexamic acid (TXA) is frequently administered prophylactically during this procedure to reduce blood loss by inhibiting fibrinolysis or by stopping naturally occurring clot resolution. TXA is employed currently based on a surgeon's preference. The objective of this study is to quantitate the degree of fibrinolysis using rotational thromboelastometry (ROTEM) and investigate the role of TXA prophylaxis on blood loss in patients undergoing THA in a double-blind fashion. Our hypothesis is that fibrinolysis is minimal at most and TXA prophylaxis is not necessary during THA. All patients, whether they receive TXA or normal saline, will not be at risk, as at this time no data exists to determine which approach is safer or more effective. This is the first study to compare TXA vs. placebo in a double-blinded, randomized controlled trial.
Detailed Description
Total hip arthroplasty (THA) is associated with moderate blood loss ranging from 300 to 2000 mL. Tranexamic acid (TXA) is frequently administered prophylactically during this procedure to reduce blood loss by inhibiting fibrinolysis. Most clinical studies reported potential benefit of the treatment demonstrated by less estimated blood loss (EBL), reduced hemoglobin/hematocrit (HH) change, and reduced transfused packed red blood cells (PRBC). However, bleeding complication may be affected more significantly by the degree of surgical trauma and comorbidity of patients than coagulation abnormality. Further, the frequency and severity of fibrinolysis during these procedures have not been well studied. Additionally, TXA administration may increase the tendency of postoperative venous thrombosis by inhibiting fibrinolysis in already prothrombotic patients. The objective of this study is to quantitate the degree of fibrinolysis using rotational thromboelastometry (ROTEM) and investigate the role of TXA prophylaxis on clinical outcome in patients undergoing THA in a double-blind fashion. Our hypothesis is that fibrinolysis is minimal at most and TXA prophylaxis is not necessary during primary THA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coagulation; Intravascular, Rotational Thromboelastometry, Fibrinolysis; Hemorrhage, Tranexamic Acid, Total Hip Arthroplasty
Keywords
tranexamic acid, Rotational thromboelastometry, Fibrinolysis, viscoelastic essay
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
double-blinded randomized controlled trial
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
tranexamic acid
Arm Type
Experimental
Arm Description
Patients undergoing unilateral, primary, total hip arthroplasty with English as their native language
Arm Title
Normal saline
Arm Type
Placebo Comparator
Arm Description
Patients undergoing unilateral, primary, total hip arthroplasty with English as their native language
Intervention Type
Drug
Intervention Name(s)
Tranexamic Acid
Intervention Description
tranexamic acid will be administered intravenously after induction of anesthesia (a bolus of 10 mg/kg or maximal dose of 1g).
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Patients in the placebo group will receive normal saline (a bolus of sodium chloride 0.9%, 0.1 mL/kg or maximal dose of 10 mL).
Primary Outcome Measure Information:
Title
Fibrinolysis
Description
Fibrinolysis based on ROTEM parameter, defined as ML (maxium lysis) >15%
Time Frame
after induction of anesthesia (baseline),
Title
Fibrinolysis
Description
Fibrinolysis based on ROTEM parameter, defined as ML (maxium lysis) >15%
Time Frame
45 min after drug administration,
Title
Fibrinolysis
Description
Fibrinolysis based on ROTEM parameter, defined as ML (maxium lysis) >15%
Time Frame
one hour after the end of surgery
Secondary Outcome Measure Information:
Title
Blood loss
Description
amount of blood loss in milliliter during surgery
Time Frame
during surgery (intraoperative)
Title
blood transfusion
Description
Amount of Packed Red Blood Cells (PRBC) transfused
Time Frame
Intraoperative and up to 72-hour after surgery
Title
pre- and postoperative hemoglobin level
Description
Pre and postoperative hemoglobin level in grams per deciliter
Time Frame
up to 72-hour after surgery
Title
Wound infection
Description
Incidence of wound infection
Time Frame
up to 72-hour after surgery
Title
Hematoma
Description
Incidence of hematoma
Time Frame
up to72-hour after surgery
Title
Thrombotic events (PE, DVT).
Description
Incidence of thrombotic events (pulmonary embolism, deep vein thrombosis)
Time Frame
up to 72-hour after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The study population will include total of 200 adults (age range of 18 - 85 years) who are in the American Society of Anesthesiologists (ASA) Physical Status (PS) 1-3. Inclusion criteria are patients undergoing unilateral, primary, total hip arthroplasty.
Exclusion Criteria:
Exclusion criteria include patient's refusal, patients with history of significant coagulopathy or on anticoagulation therapy. Female patients who are pregnant or nursing will be excluded. In addition, patients with anemia (Hb < 8 g/dL) or who received blood transfusion within one week before surgery will be excluded. Patient receiving subcutaneous heparin on the same day prior to surgery will be also excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Uzung Yoon
Organizational Affiliation
Thomas Jefferson University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Thomas Jefferson University Hospital
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
28448319
Citation
Wu Y, Yang T, Zeng Y, Si H, Cao F, Shen B. Tranexamic acid reduces blood loss and transfusion requirements in primary simultaneous bilateral total knee arthroplasty: a meta-analysis of randomized controlled trials. Blood Coagul Fibrinolysis. 2017 Oct;28(7):501-508. doi: 10.1097/MBC.0000000000000637.
Results Reference
result
PubMed Identifier
28505683
Citation
Prieto HA, Vincent HK, Deen JT, Iams DA, Parvataneni HK. Tranexamic Acid Effectively Reduces Blood Loss and Transfusion Rates during Simultaneous Bilateral Total Knee Arthroplasty. J Knee Surg. 2018 Mar;31(3):270-276. doi: 10.1055/s-0037-1603333. Epub 2017 May 15.
Results Reference
result
PubMed Identifier
26559015
Citation
Na HS, Shin HJ, Lee YJ, Kim JH, Koo KH, Do SH. The effect of tranexamic acid on blood coagulation in total hip replacement arthroplasty: rotational thromboelastographic (ROTEM(R)) analysis. Anaesthesia. 2016 Jan;71(1):67-75. doi: 10.1111/anae.13270. Epub 2015 Nov 12.
Results Reference
result
PubMed Identifier
28633147
Citation
Watts CD, Houdek MT, Sems SA, Cross WW, Pagnano MW. Tranexamic Acid Safely Reduced Blood Loss in Hemi- and Total Hip Arthroplasty for Acute Femoral Neck Fracture: A Randomized Clinical Trial. J Orthop Trauma. 2017 Jul;31(7):345-351. doi: 10.1097/BOT.0000000000000837.
Results Reference
result
PubMed Identifier
28692467
Citation
Zufferey PJ, Lanoiselee J, Chapelle C, Borisov DB, Bien JY, Lambert P, Philippot R, Molliex S, Delavenne X; investigators of the PeriOpeRative Tranexamic acid in hip arthrOplasty (PORTO) Study. Intravenous Tranexamic Acid Bolus plus Infusion Is Not More Effective than a Single Bolus in Primary Hip Arthroplasty: A Randomized Controlled Trial. Anesthesiology. 2017 Sep;127(3):413-422. doi: 10.1097/ALN.0000000000001787.
Results Reference
result
PubMed Identifier
18042876
Citation
Toledo P, McCarthy RJ, Hewlett BJ, Fitzgerald PC, Wong CA. The accuracy of blood loss estimation after simulated vaginal delivery. Anesth Analg. 2007 Dec;105(6):1736-40, table of contents. doi: 10.1213/01.ane.0000286233.48111.d8.
Results Reference
result
PubMed Identifier
9354828
Citation
Brecher ME, Monk T, Goodnough LT. A standardized method for calculating blood loss. Transfusion. 1997 Oct;37(10):1070-4. doi: 10.1046/j.1537-2995.1997.371098016448.x.
Results Reference
result
PubMed Identifier
21918164
Citation
Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen HP, Spahn DR, Baulig W. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg. 2011 Nov;113(5):1003-12. doi: 10.1213/ANE.0b013e31822e183f. Epub 2011 Sep 14.
Results Reference
result
PubMed Identifier
25098850
Citation
Ram GG, Suresh P, Vijayaraghavan PV. Surgeons often underestimate the amount of blood loss in replacement surgeries. Chin J Traumatol. 2014;17(4):225-8.
Results Reference
result
PubMed Identifier
18440953
Citation
Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008 Jun;100(6):792-7. doi: 10.1093/bja/aen083. Epub 2008 Apr 24.
Results Reference
result
Learn more about this trial
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery
We'll reach out to this number within 24 hrs